Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Expression of the anti-apoptotic protein BAG3 in human melanomas.

Franco R, Scognamiglio G, Salerno V, Sebastiani A, Cennamo G, Ascierto PA, Botti G, Turco MC, Rosati A.

J Invest Dermatol. 2012 Jan;132(1):252-4. doi: 10.1038/jid.2011.257. No abstract available.

2.

PUMA expression is significantly reduced in human cutaneous melanomas.

Karst AM, Dai DL, Martinka M, Li G.

Oncogene. 2005 Feb 3;24(6):1111-6.

PMID:
15690057
3.

XAF1 expression is significantly reduced in human melanoma.

Ng KC, Campos EI, Martinka M, Li G.

J Invest Dermatol. 2004 Dec;123(6):1127-34.

5.

Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.

Jensen EH, Lewis JM, McLoughlin JM, Alvarado MD, Daud A, Messina J, Enkemann S, Yeatman TJ, Sondak VK, Riker AI.

Ann Surg Oncol. 2007 Apr;14(4):1416-23.

PMID:
17195911
6.

Two proapoptotic genes are downregulated in a patient with melanoma and repeated in-transit metastases.

Salemi M, Giuffrida D, Soma PF, Giuffrida MC, Galia A, Calogero AE.

Am J Dermatopathol. 2012 Jun;34(4):454-5. doi: 10.1097/DAD.0b013e31820a4bd7. No abstract available.

PMID:
21986234
7.

Exposure to 50 Hz electromagnetic field raises the levels of the anti-apoptotic protein BAG3 in melanoma cells.

Basile A, Zeppa R, Pasquino N, Arra C, Ammirante M, Festa M, Barbieri A, Giudice A, Pascale M, Turco MC, Rosati A.

J Cell Physiol. 2011 Nov;226(11):2901-7. doi: 10.1002/jcp.22641.

PMID:
21302292
8.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32.

9.

[Living and letting die--new mechanisms of apoptosis resistance in melanoma cells]].

[No authors listed]

Hautarzt. 2001 Apr;52(4):386-7. German. No abstract available.

PMID:
11382133
10.

Prognostic impact of p62 expression in cutaneous malignant melanoma.

Ellis RA, Horswell S, Ness T, Lumsdon J, Tooze SA, Kirkham N, Armstrong JL, Lovat PE.

J Invest Dermatol. 2014 May;134(5):1476-8. doi: 10.1038/jid.2013.497. No abstract available.

11.

Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells.

Roesch A, Becker B, Schneider-Brachert W, Hagen I, Landthaler M, Vogt T.

J Invest Dermatol. 2006 Aug;126(8):1850-9.

13.

Growth factors and oncogenes as targets in melanoma: lost in translation?

Kwong L, Chin L, Wagner SN.

Adv Dermatol. 2007;23:99-129. Review. No abstract available.

14.

The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.

Humbert L, Ghozlan M, Canaff L, Tian J, Lebrun JJ.

BMC Cancer. 2015 Mar 29;15:200. doi: 10.1186/s12885-015-1177-1.

15.

Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.

Loria R, Bon G, Perotti V, Gallo E, Bersani I, Baldassari P, Porru M, Leonetti C, Di Carlo S, Visca P, Brizzi MF, Anichini A, Mortarini R, Falcioni R.

Oncotarget. 2015 Feb 20;6(5):2779-93.

16.

Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.

Pathria G, Wagner C, Wagner SN.

J Invest Dermatol. 2012 Dec;132(12):2780-90. doi: 10.1038/jid.2012.233.

17.

Reduced Apaf-1 expression in human cutaneous melanomas.

Dai DL, Martinka M, Bush JA, Li G.

Br J Cancer. 2004 Sep 13;91(6):1089-95.

18.

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS, Testori A, Larue L, Goding CR.

Genes Dev. 2006 Dec 15;20(24):3426-39.

19.

KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.

Huh SJ, Chen YL, Friedman SL, Liao J, Huang HJ, Cavenee WK, Robertson GP.

J Natl Cancer Inst. 2010 Aug 4;102(15):1131-47. doi: 10.1093/jnci/djq218.

20.

Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma.

Lee DA, Cohen JA, Twaddell WS, Palacios G, Gill M, Levit E, Halperin AJ, Mones J, Busam KJ, Silvers DN, Celebi JT.

Cancer. 2006 Feb 15;106(4):907-13.

Items per page

Supplemental Content

Support Center